InMed Pharmaceuticals's total assets for Q3 2025 were $9.28B, an increase of 109045.09% from the previous quarter. INM total liabilities were $2.26B for the fiscal quarter, a 97232.85% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.